Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeladon Pharmaceuticals Regulatory News (CEL)

  • This share is currently suspended. It was suspended at a price of 13.40
  • There is currently no data for CEL

Share Consolidation

30 Aug 2005 11:43

Celsis International PLC30 August 2005 Celsis International Plc Share consolidation update 30 August 2005 Celsis International Plc (the "Company") confirms that the consolidation of itsshare capital approved by shareholders on 26 July 2005 was finalised at close ofbusiness on 26 August 2005. The consolidation was conducted on the basis of onenew 5p ordinary share in the Company for each five ordinary shares of 1p eachheld in the Company at close of business on 26 August 2005. As a result of the consolidation of the share capital, the current issued sharecapital of the company comprises 22,483,043 ordinary shares of 5p each. All ofthese shares have been admitted to the Official List and to trading on theLondon Stock Exchange. The full names and code numbers for the two classes of shares are as follows: Ordinary shares of 5p each: Reuters CEL.L Bloomberg CEL:LN ISIN GB00B0C05F69 For further information please contact: Celsis International plc Tel: 01638 600 151 Christian Madrolle, Finance Director & Company Secretary Jenny Parsons, Corporate Communications END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Jun 20235:30 pmRNSResult of AGM
5th Jun 20232:46 pmRNSPublication of Annual Report and Notice of AGM
5th Jun 20237:00 amRNSFinal Results for the year ended 31 December 2022
30th May 20237:00 amRNS£7 Million Committed Credit Facility
26th May 20237:00 amRNSNotice of Results and Investor Presentation
25th May 20237:00 amRNSWest Midlands Mayor Visits Celadon’s Facility
24th May 20237:00 amRNSInaugural Supply Contract Win
29th Mar 202311:05 amRNSSecond Price Monitoring Extn
29th Mar 202311:00 amRNSPrice Monitoring Extension
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20232:05 pmRNSSecond Price Monitoring Extn
17th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20233:01 pmRNSSuccessful Update to Home Office Licence
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20239:05 amRNSSecond Price Monitoring Extn
13th Mar 20239:00 amRNSPrice Monitoring Extension
10th Mar 20234:40 pmRNSSecond Price Monitoring Extn
10th Mar 20234:35 pmRNSPrice Monitoring Extension
10th Mar 20232:05 pmRNSSecond Price Monitoring Extn
10th Mar 20232:00 pmRNSPrice Monitoring Extension
10th Feb 20232:15 pmRNSNotification of transaction by PDMR
19th Jan 20237:00 amRNSChange of Website Address
16th Jan 20237:00 amRNSApproval of GMP Registration by MHRA
13th Jan 20237:00 amRNSUpdate on CFO Appointment
30th Dec 20227:00 amRNSResults of Feasibility Study
22nd Dec 20227:00 amRNSUpdate on GMP Registration by MHRA
1st Nov 20227:00 amRNSAppointment of CFO
29th Sep 20227:00 amRNSInterim Report for six months ended 30 June 2022
12th Sep 20227:00 amRNSNotice of Results
28th Jul 20227:00 amRNSAppointment of Tessera Investment Management
27th Jun 20226:15 pmRNSResult of AGM
22nd Jun 20227:00 amRNSBusiness Update
31st May 20221:30 pmRNSNotice of AGM
29th Apr 20227:00 amRNSFull year results
29th Apr 20227:00 amRNSFull year results
31st Mar 20228:08 amRNSHolding(s) in Company
30th Mar 20224:41 pmRNSSecond Price Monitoring Extn
30th Mar 20224:36 pmRNSPrice Monitoring Extension
29th Mar 20228:00 amRNSChange of Name
7th Oct 20099:56 amRNSHolding(s) in Company
1st Oct 20096:29 pmRNSTransfers from Treasury and Admission of Shares
30th Sep 200910:50 amRNSHolding(s) in Company
24th Sep 20097:00 amRNSClosing of the Offer
9th Sep 20094:26 pmRNSCancellation of Listing
9th Sep 200912:56 pmRNSOffer Update
4th Sep 200911:57 amRNSDirector Declaration
3rd Sep 20097:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.